Medtronic Plc

NYSE:MDT   9:48:25 AM EDT
-0.10 (-0.08%)

Medtronic Announces FDA Approval Of Next-Gen Tavr System For Treatment Of Symptomatic Severe Aortic Stenosis

Published: 08/24/2021 13:25 GMT
Medtronic Plc (MDT) - Medtronic Announces FDA Approval of Next-gen Tavr System for Treatment of Symptomatic Severe Aortic Stenosis.
Medtronic Plc - Limited Commercial Release is Planned for Fall With a Full Launch Anticipated in Early 2022 for Evolut Tavr Platform.